-
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
-
Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection
-
令人难以置信的 Jeff！ IriusRisk 推出一款人工智能驱动的工具，可通过图像生成威胁模型
-
UPDATE – Politecnico di Torino as a Driving Force in Space Research
-
Unbelievable Jeff! IriusRisk introduces an AI-powered tool which can generate threat models from images
-
大道至简 知行合一
-
李宁联手红杉中国成立合资公司 探索海外业务新路径
-
“金秋敬老月 浓浓孝老情”2024中益孝行大爱进万家敬老月公益活动走进涿州
-
全新Fluke 1670 系列多功能安装测试仪——测试速度提高30%，报告时间减少50%
-
文化中国行（书画篇）走进艺术家：李润德
-
文化中国行（书画篇）走进艺术家：沈安良
-
文化中国行（书画篇）走进艺术家：王天晞
-
金蓓高亮相中华中医药学会儿科分会第四十一次学术大会
-
中芯聚源考察团到访“武汉鑫威源”
-
首届“社会心理服务产业化创业经验交流会”即将在北京举办
-
好医生攀西药业：开足马力忙生产、赶订单 深抓产品开发
-
2024第四届仲景“三分钟讲透经典”总决赛圆满结束
-
高文祥——悠游于生活之上，笔转艺术之瑰宝
-
NIKE, Inc. Signs Historic Partnership Extension With NBA, WNBA and NBA G League Through 2037
-
U.S. Department of Commerce Removes Sandvine from Entity List Following Company’s Democracy-Only Business Realignment
小米SU7 Ultra将亮相广州车展
微博视界大会众明星谁是赢家